---
DrugClass: "[[Cardiotonic and Antiarrhythmic Drugs]]"
SubClass: "[[Antiarrhythmics]]"
DrugClassContra: "[[Antiarrhythmics#Contraindications]]"
DrugClassAdverse: "[[Antiarrhythmics#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
BrandName: Norpace, Norpace CR
Chapter: "37"
KindleLinkChap: "[Chapter 37](kindle://book?action=open&asin=B09FRF11YJ&location=20599)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases:
---
```smiles
CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
```
Class I: Sodium Channel Blockers
### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Life-threatening ventricular arrhythmias
Ventricular arrhythmias: dosage individualized, 400â€“ 800 mg/ day orally in divided doses

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Dry [[Mouth]], constipation, urinary hesitancy, blurred [[Vision]], nausea, fatigue, dizziness, headache, rash, hypotension, HF, [[proarrhythmic effect]]

### Interactions

`= this.ChemLink+this.file.name`

